Trial · NCT04209205
Adverse events86
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 86
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Diarrhoea | Gastrointestinal disorders | AIN457 6 mg/kg - 3 mg/kg i.v | 9 | 374 | |
| other | Diarrhoea | Gastrointestinal disorders | Placebo up to Week 16 | 2 | 190 | |
| other | Nausea | Gastrointestinal disorders | AIN457 6 mg/kg - 3 mg/kg i.v | 11 | 374 | |
| other | Nausea | Gastrointestinal disorders | Placebo up to Week 16 | 2 | 190 | |
| other | Bronchitis | Infections and infestations | AIN457 6 mg/kg - 3 mg/kg i.v | 8 | 374 | |
| other | Bronchitis | Infections and infestations | Placebo up to Week 16 | 0 | 190 | |
| other | COVID-19 | Infections and infestations | AIN457 6 mg/kg - 3 mg/kg i.v | 37 | 374 | |
| other | COVID-19 | Infections and infestations | Placebo up to Week 16 | 7 | 190 | |
| other | Nasopharyngitis | Infections and infestations | AIN457 6 mg/kg - 3 mg/kg i.v | 13 | 374 | |
| other | Nasopharyngitis | Infections and infestations | Placebo up to Week 16 | 3 | 190 | |
| other | Pharyngitis | Infections and infestations | AIN457 6 mg/kg - 3 mg/kg i.v | 9 | 374 | |
| other | Pharyngitis | Infections and infestations | Placebo up to Week 16 | 1 | 190 | |
| other | Upper respiratory tract infection | Infections and infestations | AIN457 6 mg/kg - 3 mg/kg i.v | 10 | 374 | |
| other | Upper respiratory tract infection | Infections and infestations | Placebo up to Week 16 | 6 | 190 | |
| other | Urinary tract infection | Infections and infestations | AIN457 6 mg/kg - 3 mg/kg i.v | 17 | 374 | |
| other | Urinary tract infection | Infections and infestations | Placebo up to Week 16 | 1 | 190 | |
| other | Alanine aminotransferase increased | Investigations | AIN457 6 mg/kg - 3 mg/kg i.v | 12 | 374 | |
| other | Alanine aminotransferase increased | Investigations | Placebo up to Week 16 | 4 | 190 | |
| other | Aspartate aminotransferase increased | Investigations | AIN457 6 mg/kg - 3 mg/kg i.v | 11 | 374 | |
| other | Aspartate aminotransferase increased | Investigations | Placebo up to Week 16 | 2 | 190 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04209205/events